Medicine and Dentistry
Acrylamide
8%
Arm
8%
Biliary Tract Disease
8%
Bleeding
8%
Body Mass Index
8%
Cancer Risk
15%
Carcinoma Cell
8%
Clear Cell Renal Cell Carcinoma
23%
Colorectal Carcinoma
16%
Congestive Heart Failure
8%
Cytotoxic T-Cell
8%
Depressive Disorder
5%
Dose Response
5%
Everolimus
6%
Homocysteine
8%
Immune Checkpoint Inhibitor
8%
Immune-Related Adverse Events
8%
Logistic Regression Analysis
5%
Mammalian Target of Rapamycin Inhibitor
20%
Meta-Analysis
80%
Neoplasm
7%
Observational Study
8%
Odds Ratio
17%
Programmed Cell Death
8%
Programmed Death 1 Ligand 1
8%
Prospective Cohort Study
26%
Prospective Study
16%
Protein Tyrosine Kinase
21%
Pyridoxal 5 Phosphate
8%
Pyridoxine
8%
Random Effects Model
10%
Randomized Clinical Trial
12%
Sorafenib
8%
Sunitinib
16%
Temsirolimus
6%
Thromboembolism
5%
Tyrosine-Kinase Inhibitor
21%
Uterine Cancer
12%
Vasculotropin Receptor
20%
Vitamin D
8%
Pharmacology, Toxicology and Pharmaceutical Science
All Cause Mortality
12%
Androgen
8%
Anemia
7%
Ascorbic Acid
5%
Bevacizumab
16%
Bleeding
8%
Cancer Mortality
6%
Carcinoma
8%
Cardiovascular System Cancer
5%
Colorectal Carcinoma
8%
Congestive Heart Failure
16%
Dietary Supplement
8%
Everolimus
6%
Immune Checkpoint Inhibitor
8%
Mammalian Target of Rapamycin Inhibitor
20%
Metabolic Syndrome X
12%
Neoplasm
9%
Neutropenia
7%
Observational Study
5%
Prevalence
5%
Programmed Cell Death
8%
Programmed Death 1 Ligand 1
8%
Prospective Cohort Study
15%
Prospective Study
8%
Prostate Cancer
8%
Protein Tyrosine Kinase
45%
Protein Tyrosine Kinase Inhibitor
40%
Random Effects Model
11%
Randomized Clinical Trial
13%
Randomized Controlled Trial
10%
Renal Cell Carcinoma
23%
Sorafenib
23%
Sunitinib
24%
Temsirolimus
6%
Thrombocytopenia
7%
Thromboembolism
9%
Vasculotropin Receptor
37%
Agricultural and Biological Sciences
Body Mass Index
14%
Cardiovascular System
16%
Confidence Interval
84%
Cross-Sectional Study
6%
Dairy Consumption
28%
Dietary Fiber
12%
Fish Consumption
16%
Meta-Analysis
100%
National Health and Nutrition Examination Survey
8%
Observational Studies
8%
Odds Ratio
17%
Receptor Tyrosine Kinase
8%
Relative Risk
53%
Risk Factor
6%
Spider Web
7%
Vascular Endothelial Growth Factor Receptors
8%
Vitamin B6
8%
